ASXL1 Mutations in AML: Molecular Biomarker for Secondary AML?

被引：0

作者：

Hsu, Jingmei ^{[1
]}

Kumar, Anita J. ^{[1
]}

Carroll, Martin P. ^{[1
]}

Frey, Noelle V. ^{[1
]}

Shah, Nirav N. ^{[1
,2
]}

Jianhua, Zhao ^{[3
]}

Hexner, Elizabeth O. ^{[1
]}

Loren, Alison W. ^{[1
]}

Mangan, James K. ^{[1
]}

Perl, Alexander E. ^{[1
]}

Porter, David ^{[1
]}

Morrissette, Jennifer ^{[3
]}

Luger, Selina M. ^{[1
]}

机构：

[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[2] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

[3] Hosp Univ Penn, Philadelphia, PA 19104 USA

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[41] ASXL1 Mutations Predict for Resistance to Chemotherapy and Inferior Outcome in Younger Adult Patients with Acute Myeloid Leukemia (AML): A Study of the German-Austrian AMLSG [J].

Paschka, Peter ;

Schlenk, Richard F. ;

Herzig, Julia ;

Aulitzky, Teresa ;

Gaidzik, Verena I. ;

Bullinger, Lars ;

Habdank, Marianne ;

Corbacioglu, Andrea ;

Spaeth, Daniela ;

Koehne, Claus-Henning ;

Kuendgen, Andrea ;

von Lilienfeld-Toal, Marie ;

Held, Gerhard ;

Horst, Heinz A. ;

Goetze, Katharina ;

Bentz, Martin ;

Krauter, Juergen ;

Ganser, Arnold ;

Doehner, Hartmut ;

Doehner, Konstanze .

BLOOD, 2011, 118 (21) :189-189

[42] PROGNOSTIC VALUE OF MUTATIONS IN ASXL1 IN CHRONIC MYELOMONOCYTIC LEUKEMIA [J].

Almorox Rebeca, Bailen ;

Gonzalez Julia, Suarez ;

Carolina, Martinez-Laperche ;

Noemi, Fernandez-Escalada ;

Maria, Chicano-Lavilla ;

Diego, Carbonell ;

Patricia, Font ;

Santiago, Osorio ;

Jose Lui, Diez-Martin ;

Ismael, Buno .

HAEMATOLOGICA, 2016, 101 :153-154

[43] Categorizing Molecular Mutations in MDS and AML [J].

Rose, Dominic ;

Haferlach, Torsten ;

Kern, Wolfgang ;

Haferlach, Claudia .

BLOOD, 2015, 126 (23)

[44] Focusing on frequent ASXL1 mutations in myeloid neoplasms, and considering rarer ASXL2 and ASXL3 mutations [J].

Oak, Jean S. ;

Ohgami, Robert S. .

CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (04) :781-782

[45] Analysis of ASXL1 Mutations in a Large Series of Myeloid Malignancies [J].

Van Ness, Michael ;

Szankasi, Philippe ;

Frizzell, Kimberly ;

Shen, Wei ;

Kelley, Todd W. .

MODERN PATHOLOGY, 2016, 29 :381A-381A

[46] Analysis of ASXL1 Mutations in a Large Series of Myeloid Malignancies [J].

Van Ness, Michael ;

Szankasi, Philippe ;

Frizzell, Kimberly ;

Shen, Wei ;

Kelley, Todd W. .

LABORATORY INVESTIGATION, 2016, 96 :381A-381A

[47] Molecular Pathways Mediating MDS/AML With Focus on AML1/RUNX1 Point Mutations [J].

Harada, Yuka ;

Harada, Hironori .

JOURNAL OF CELLULAR PHYSIOLOGY, 2009, 220 (01) :16-20

[48] Mutations of ASXL1 and TET2 in aplastic anemia [J].

Huang, Jinbo ;

Ge, Meili ;

Lu, Shihong ;

Shi, Jun ;

Li, Xingxin ;

Zhang, Jizhou ;

Wang, Min ;

Yu, Wei ;

Shao, Yingqi ;

Huang, Zhendong ;

Zhang, Jing ;

Nie, Neng ;

Zheng, Yizhou .

HAEMATOLOGICA, 2015, 100 (05)

[49] Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes [J].

Thol, Felicitas ;

Friesen, Inna ;

Damm, Frederik ;

Yun, Haiyang ;

Weissinger, Eva M. ;

Krauter, Juergen ;

Wagner, Katharina ;

Chaturvedi, Anuhar ;

Sharma, Amit ;

Wichmann, Martin ;

Goehring, Gudrun ;

Schumann, Christiane ;

Bug, Gesine ;

Ottmann, Oliver ;

Hofmann, Wolf-Karsten ;

Schlegelberger, Brigitte ;

Heuser, Michael ;

Ganser, Arnold .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18) :2499-2506

[50] RUNX1-mutant AML Has Similar Outcome to AML with Other Secondary-type Mutations [J].

Loneman, Derek ;

Cantu, Miguel ;

Weinberg, Olga ;

Hasserjian, Robert .

LABORATORY INVESTIGATION, 2024, 104 (03) :S1446-S1448

← 1 2 3 4 5 →